Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
217.1 USD | -0.21% | -2.48% | -8.58% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.58% | 11.21B | |
+67.12% | 62.86B | |
-1.14% | 41.38B | |
+45.72% | 40.38B | |
-8.93% | 27.64B | |
+14.18% | 26.46B | |
-22.44% | 18.9B | |
+4.20% | 12.67B | |
+23.74% | 12.27B | |
+28.23% | 12.07B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280